Journal of Gorgan University of Medical Sciences / 76 2020 Spring / Vol 22 / No 1 Original Paper Article ID: Vol22-10 Survival rate of gasteric cancer in Golestan provience (north of Iran) Siamak Razaei (M.D), Assistant Professor, Department of Surgery, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. ORCID ID: 0000-0003-4392-1697 *Mohammad Hossein Taziki (M.D), Corresponding Author, Associate Professor, Department of Surgery, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. E-mail: hoseinta@yahoo.com ORCID ID: 0000-0001-6288-4663 Nasser Behnampour (Ph.D), Ph.D in Biostatistics, Assistant Professor, School of Health, Golestan University of Medical Sciences, Gorgan, Iran. ORCID ID: 0000-0003-1668-8922 Reza Shahsavani (M.D), Hematologist - Oncologist, Gorgan, Iran. Seyyed Shfie Shafiepour (M.D), Cardiologist, Tehran University of Medical Scineces, Tehran. Iran. _______________________________________________________________________________________________ Abstract Background and Objective: Due to high incidence and mortality of gasteric cancer and important of clinical symptoms to early diagnosis and tertment; this stady was done to determine the survival rate of gasteric cancer in Golestan provience (north of Iran). Methods: This retrospective cohort stady was done on 131 patients (77.9% males and 22.1% females) with adeno carcinoma gasteric cancer wich diagosed during 2007-09 in northern Iran. Age, sex, job, nationality and tribe clincal presentation kind of treatment food regiemns, survival collected from archive. In cases whom nesacery data completed with telophone calling or face to face interview. Survival rate of patients for 1, 3 and 5 years were determined using caplan Mayer method. Results: First symptom in 31.3% of patients was abdominl pain and distance between the first symptom and diagnosis was 1-14 months. 34.4% of patient did not receive any treatment. Survivial rate for 1, 3 and 5 years was 37.4%, 13% and 6.1%, respectively. Age, gender and ethnicity did not not altere survival rate but type of treatment had significant relation to survival rate (P<0.05). Conclusion: The diagnosis of gasteric cancer in early stage and surgical treatment can help a better survival rate in patients with adeno carcinoma gasteric cancer in northern Iran. Keywords: Gastric cancer, Epidemiology, Survival, Iran _______________________________________________________________________________________________ Received 27 Feb 2019 Revised 11 Aug 2019 Accepted 24 Aug 2019 Cite this article as: Razaei S, Taziki MH, Behnampour N, Shahsavani R, Shafiepour SS. [Survival rate of Gasteric cancer in Golestan provience (north of Iran)]. J Gorgan Univ Med Sci. 2020 Spring; 22(1): 71-76. [Article in Persian]